Stimulation of regressing subordinate follicles of wave 2 with a gonadotropin product in heifers

Abstract

The recovery of regressing wave-2 subordinate follicles was studied by treating heifers with a gonadotropin product that had about 84% and 16% of follicle-stimulating hormone and luteinizing hormone activity, respectively. A treated group (n = 8) received a single dose of 50 mg (2.5 mL) of the gonadotropin product, and a control group (n = 8) received 2.5 mL of saline vehicle. The group assignment of heifers was not known to the ultrasonographer who tracked the follicles and measured follicle diameters. Follicle measurements began on the day of expected follicle deviation in wave 2 (largest follicle closest to 8.5 mm), and treatment (hour 0) was given on Day 13.4 ± 0.2 (Day 0 = ovulation) when the dominant follicles of waves 1 and 2 were 14.1 ± 0.3 mm and 10.7 ± 0.1 mm, respectively. Subordinate follicles of wave 2 that had regressed to a 3-mm category (3.0–3.9 mm) or 4-mm category by hour 0 decreased in diameter for at least 48 h before hour 0, whereas follicles that were in the 5-mm or 6-mm categories at hour 0 did not change significantly in diameter during the previous 48 h. About 55% of the follicles that had regressed to the 3-mm and 4-mm categories at hour 0% and 78% of the follicles in the 5-mm and 6-mm categories increased in diameter after gonadotropin treatment, whereas follicles in the control group continued to decrease (regress) in diameter. The follicles for each of the 4 diameter categories were greater (P < 0.05) in diameter 9 h after treatment in the treated group than in the control group. The dominant follicle of wave 1 and the largest subordinate follicle of wave 2 in the treated group also increased in diameter so that diameter was greater (P < 0.05) than in the controls at hour 9. The results demonstrated that subordinate follicles of wave 2 that had decreased in diameter (regressed) for at least 48 h retained the capability to recover as indicated by a diameter increase when exposed to a gonadotropin product.